Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results
Date:2/28/2012

sation expense. We believe that excluding the impact of expensing stock options better reflects the recurring economic characteristics of our business.

Non-GAAP net income may exclude unusual or non-recurring items that are evaluated on an individual basis. Our evaluation of whether to exclude an item for purposes of determining our non-GAAP financial measures considers both the quantitative and qualitative aspects of the item, including, among other things (i) its size and nature, (ii) whether or not it relates to our ongoing business operations, and (iii) whether or not we expect it to occur as part of our normal business on a regular basis. For purposes of determining non-GAAP net income, the asset impairment is excluded.

VIROPHARMA INCORPORATEDSelected Financial InformationSelected Consolidated Balance Sheet DataDecember 31,December 31,(in thousands)

20112010AssetsCurrent assets:Cash and cash equivalents

$
331,352$
426,732Short-term investments

128,47878,439Inventory

60,31654,388Total current assets

635,931633,141Intangible assets, net

648,659619,712Goodwill

13,1846,228Total assets

1,336,7971,287,574Liabilities and Stockholders’ EquityTotal current liabilities

98,65172,122Deferred tax liabilities

178,706176,111Long-term debt

153,453145,743Total liabilities

445,673396,439Total stockholders’ equity

891,124891,135Total liabilities and stockholders’ equity

1,336,7971,287,574 Years Ended December 31,December 31,Statement of Cash Flows:20112010(in thousands)Net cash provided by operating activities

$
70,726$
93,517Net cash used in investing activities

$
(101,047)$
(101,934)Net cash (used in) provided by financing activities

$
(163,214)$
3,565
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. ViroPharma to Present at Three September Healthcare Conferences
2. ViroPharma to Present at Three October Healthcare Conferences
3. ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
4. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
5. ViroPharma to Present at Three November Healthcare Conferences
6. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
7. ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes
8. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
9. ViroPharma Incorporated Reports First Quarter 2009 Financial Results
10. ViroPharma Incorporated Honored by the National Organization for Rare Disorders
11. ViroPharma to Present at Two June Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... August 3, 2015 According to ... 3D Cell Culture: Asia to ... Research, the global 3D cell culture market was valued at US$ ... at a CAGR of 29.1% to account for US$ ... with TOC:  http://www.persistencemarketresearch.com/market-research/3d-cell-cultures-market.asp 3D cell culture ...
(Date:7/31/2015)... Texas (PRWEB) , ... July 31, 2015 , ... ... report, offering competitive market analysis and premium industry insights on the global resorcinol ... based on a collective study of vivid market scenarios and analysis of primary ...
(Date:7/30/2015)... AACC welcomed thousands of medical professionals ... Meeting & Clinical Lab Expo in ... showcased revolutionary advancements in clinical testing technology and ... to diagnose patients quickly and accurately and make ... As of Wednesday, July 29, more than ...
(Date:7/30/2015)... Washington , July 30, 2015 ... Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial ... Discovery & Development, Preclinical, Clinical Trial), by End Users ... Biosimulation Market is expected to reach USD 2,107.99 million ... a CAGR of 15.29%. Browse more ...
Breaking Biology Technology:Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 4Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4
... 7, 2008 BioSpace, the world,s,leading online bioscience ... host a Private Label Career Fair for Regeneron ... take place at the Hanover Marriott,in Whippany, New ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080222/CLF013LOGO ), Regeneron is ...
... SAN FRANCISCO, April 7, 2008 BioSpace, the ... career fair company,is hosting a Private Label Career ... Boston, Massachusetts. The event will be held at ... pm., (Logo: http://www.newscom.com/cgi-bin/prnh/20080222/CLF013LOGO ), ...
... Bluestar Silicones,introduces a new range of Silbione(R) brand ... market that provide a unique combination,of strong physical ... durometers., These new low durometer products incorporate ... to 70- ShA LSR product,line, including easy processing, ...
Cached Biology Technology:BioSpace to Host Regeneron Pharmaceuticals Career Fair in Whippany, New Jersey 2Boehringer Ingelheim and BioSpace Search for Scientists at Career Fair in Boston, Massachusetts 2Bluestar Silicones Introduces Three New Soft and Durable Liquid Silicone Rubber Products 2
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier of ... second quarter ended June 30, 2015.  Revenue ... decrease of 33% compared to $6.8 million in the same ... 2015 was $0.3 million, or $0.01 per diluted share, which ... the same period a year ago.  Lower ...
(Date:7/20/2015)... July 20, 2015  Acuity Market Intelligence,s latest ... Convergence of Commerce and Privacy" forecasts that between ... apps will be downloaded to smart mobile devices ... biometrics market is projected to generate more than ... the seven-year forecast period.    "Biometrics ...
(Date:7/9/2015)... 9, 2015  Unchained Labs just can,t get ... of Avid Nano. Avid Nano designs, develops and ... Also today, Unchained Labs UNcaged ... to use protein sizing system. The pUNk is ... hydrodynamic size, size distribution, aggregation population and molecular ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... intelligence community seek out strategies that will give them ... Houston researchers are developing innovative techniques and devices to ... pairing of tactical and technical expertise will be showcased ... Defense Research Conference. "UH researchers are in pursuit ...
... strain called H5N1 forms tiny tubules in which it "hides" ... otherwise would prompt an antiviral immune response from infected cells, ... in the journal Nature . Two domains or ... where double-stranded RNA is hidden from the immune system, said ...
... The universe is full of water, mostly in ... on interstellar dust particles, but until recently little ... Now the latest quick freezing techniques coupled with ... to create ice films in cold conditions similar ...
Cached Biology News:Research conference at UH to focus on US troops' needs, homeland security 2Protein 'tubules' free avian flu virus from immune recognition 2Very cold ice films in laboratory reveal mysteries of universe 2Very cold ice films in laboratory reveal mysteries of universe 3